- Member of HKPM Board
Nisa Leung is a Managing Partner of Qiming Venture Partners and leading its health care investments. Qiming Venture Partners is a leading investment firm in China which currently manages investment in over 480 companies.
She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:09688), CanSino Biologics (SSE:688185; HKSE:06185), Caidya, Chain Medical Labs, Berry Oncology, Belief BioMed, ZhenGe Biotech, Alamar Biosciences among others.
Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019, 2020, 2021 and 2022 and named Best Women VCs List by Forbes China (#1 in 2022, #2 in 2021) and Most Powerful Women in Business by Fortune China in 2022.
Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as an independent non-executive director of the Hong Kong Exchanges and Clearing Limited, Board Member of the Hong Kong Palace Museum, Council Member of China Pharmaceutical Innovation and Research Development Association (PhIRDA) and Founding Member and Chair of Pharmaceutical Innovation Investment Specialty Committee of PhIRDA.
